CIBRA Capital Ltd Invests $1.36 Million in Surgery Partners, Inc. (NASDAQ:SGRY)

CIBRA Capital Ltd purchased a new stake in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 57,117 shares of the company's stock, valued at approximately $1,357,000. Surgery Partners comprises 0.5% of CIBRA Capital Ltd's investment portfolio, making the stock its 20th largest position.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Principal Financial Group Inc. raised its stake in Surgery Partners by 8.8% during the fourth quarter. Principal Financial Group Inc. now owns 49,549 shares of the company's stock valued at $1,049,000 after buying an additional 3,997 shares in the last quarter. Bank of New York Mellon Corp raised its stake in Surgery Partners by 17.7% during the fourth quarter. Bank of New York Mellon Corp now owns 340,776 shares of the company's stock valued at $7,214,000 after buying an additional 51,187 shares in the last quarter. Charles Schwab Investment Management Inc. raised its stake in Surgery Partners by 8.0% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 834,417 shares of the company's stock valued at $17,665,000 after buying an additional 61,671 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in Surgery Partners during the fourth quarter valued at approximately $10,130,000. Finally, First Eagle Investment Management LLC raised its stake in Surgery Partners by 17.3% during the fourth quarter. First Eagle Investment Management LLC now owns 292,278 shares of the company's stock valued at $6,188,000 after buying an additional 43,100 shares in the last quarter.

Wall Street Analyst Weigh In

Several analysts have issued reports on SGRY shares. Benchmark restated a "buy" rating and set a $35.00 price objective on shares of Surgery Partners in a research note on Monday, April 21st. Royal Bank Of Canada restated an "outperform" rating and set a $35.00 price objective on shares of Surgery Partners in a research note on Tuesday, March 25th. Macquarie cut their price objective on Surgery Partners from $34.00 to $33.00 and set an "outperform" rating on the stock in a research note on Tuesday, March 11th. Finally, Barclays dropped their price target on Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 27th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $33.56.

Surgery Partners Price Performance

Shares of SGRY stock traded up $0.13 during mid-day trading on Friday, hitting $22.15. 770,143 shares of the stock traded hands, compared to its average volume of 1,207,457. Surgery Partners, Inc. has a twelve month low of $18.87 and a twelve month high of $33.97. The firm has a market cap of $2.84 billion, a price-to-earnings ratio of -14.48 and a beta of 1.90. The company's 50-day simple moving average is $22.49 and its 200-day simple moving average is $22.71. The company has a debt-to-equity ratio of 1.09, a quick ratio of 1.73 and a current ratio of 1.89.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last issued its quarterly earnings results on Monday, May 12th. The company reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.08 by ($0.04). The firm had revenue of $776.00 million for the quarter, compared to analyst estimates of $777.77 million. Surgery Partners had a negative net margin of 6.10% and a positive return on equity of 2.41%. The firm's revenue for the quarter was up 8.2% compared to the same quarter last year. During the same quarter last year, the business posted $0.10 earnings per share. As a group, equities research analysts expect that Surgery Partners, Inc. will post 0.67 earnings per share for the current year.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.